{"id":7704,"date":"2021-12-16T10:28:57","date_gmt":"2021-12-16T15:28:57","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/tesamoreliini-usan-tesamorelin-cas-218949-48-5-hivhen-liittyvan-lipidiaineenvaihduntahairion-oireyhtyman-hoitoon\/"},"modified":"2021-12-16T10:28:57","modified_gmt":"2021-12-16T15:28:57","slug":"tesamoreliini-usan-tesamorelin-cas-218949-48-5-hivhen-liittyvan-lipidiaineenvaihduntahairion-oireyhtyman-hoitoon","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/fi\/product\/tesamoreliini-usan-tesamorelin-cas-218949-48-5-hivhen-liittyvan-lipidiaineenvaihduntahairion-oireyhtyman-hoitoon\/","title":{"rendered":"Tesamoreliini (usan) \/ Tesamorelin CAS 218949-48-5 HIV:hen liittyv\u00e4n lipidiaineenvaihduntah\u00e4iri\u00f6n oireyhtym\u00e4n hoitoon"},"content":{"rendered":"<h2><strong>Tesamoreliini (usan) \/ Tesamorelin CAS 218949-48-5 HIV:hen liittyv\u00e4n lipidiaineenvaihduntah\u00e4iri\u00f6n oireyhtym\u00e4n hoitoon<\/strong><\/h2>\n<p>Tuotteen nimi: Tesamoreliini (usan)<br \/>\nSynonyymit: D06655;Tesamoreliini (usan);Tesamoreliiniasetaatti;Kuumamyynti farmaseuttiset peptidit 2mg Tesamoreliini 99%;Tesamoreliini (usan) USP\/EP\/BP9-4&gt;8C9 -5<br \/>\nMF:<br \/>\nMW: 0<br \/>\nEINECS: 603-809-2<br \/>\nTuoteluokat:<br \/>\nMol-tiedosto: Mol-tiedosto<\/p>\n<p>Tesamoreliini on synteettinen peptidi, joka koostuu hGRF:n kaikki 44 aminohappoa, joihin on lis\u00e4tty trans-3-hekseenihapporyhm\u00e4. Tesamoreliini (tunnetaan my\u00f6s nimell\u00e4 Egrifta) on kasvuhormonia vapauttavan hormonin synteettinen muoto, jota k\u00e4ytet\u00e4\u00e4n HIV:hen liittyv\u00e4n lipodystrofian hoidossa.j\u00e4nne fibroblasteja annoksesta riippuvaisella tavalla, kuten transwell-suodattimen migraatiom\u00e4\u00e4rityksess\u00e4 paljastui. BPC 157 kiihdytti my\u00f6s annosriippuvaisesti j\u00e4nnefibroblastien levi\u00e4mist\u00e4 viljelymaljoilla. F-aktiinin muodostuminen, joka havaittiin FITC-falloidiiniv\u00e4rj\u00e4yksell\u00e4, indusoitiin BPC 157:ll\u00e4 k\u00e4sitellyiss\u00e4 fibroblasteissa. FAK:n ja paksilliinin proteiinin ilmentyminen ja aktivaatio m\u00e4\u00e4ritettiin Western blot -analyysill\u00e4, ja sek\u00e4 FAK:n ett\u00e4 paksilliinin fosforylaatiotasot kasvoivat annosriippuvaisesti BPC 157:ll\u00e4, kun taas proteiinin kokonaism\u00e4\u00e4r\u00e4t pysyiv\u00e4t muuttumattomina. Yhteenvetona voidaan todeta, ett\u00e4 BPC 157 edist\u00e4\u00e4 j\u00e4nnefibroblastien ex vivo uloskasvua j\u00e4nneeksplanteista, solujen selviytymist\u00e4 stressiss\u00e4 ja j\u00e4nnefibroblastien migraatiota in vitro, mik\u00e4 on todenn\u00e4k\u00f6isesti FAK-paksilliinireitin aktivoitumisen v\u00e4litt\u00e4m\u00e4\u00e4.<br \/>\n&lt;&amp; &gt; <strong>Tesamorelin-sovellukset<\/strong> <\/p>\n<p>1. Triptoreliini nostaa testosteronitasoja aiheuttamalla jatkuvaa aivolis\u00e4kkeen stimulaatiota, se v\u00e4hent\u00e4\u00e4 aivolis\u00e4kkeen gonadotropiinien luteinisoivan hormonin (LH) ja follikkelia stimuloivan hormonin (FSH) erityst\u00e4.<\/p>\n<p>2. Kuten muitakin GnRH-agonisteja, triptoreliinia voidaan k\u00e4ytt\u00e4\u00e4 hormoneihin reagoivien sy\u00f6pien, kuten eturauhassy\u00f6v\u00e4n tai rintasy\u00f6v\u00e4n, ennenaikaisen murrosi\u00e4n, estrogeeniriippuvaisten tilojen (kuten endometrioosin tai kohdun fibroidien) hoidossa ja avusteisessa lis\u00e4\u00e4ntymisess\u00e4.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tuotteen nimi: Tesamorelin (usan)<br \/>\nCAS: 218949-48-5<br \/>\nEINECS: 603-809-2<br \/>\nMol File: Mol File<\/p>\n","protected":false},"featured_media":2163,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[532],"product_tag":[2053],"class_list":{"0":"post-7704","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-muut-peptidit","7":"product_tag-tesamorelin-usan-tesamorelin-cas-218949-48-5-for-the-treatment-of-hiv-associated-lipid-metabolism-disorder-syndrome-fi","8":"desktop-align-left","9":"tablet-align-left","10":"mobile-align-left","12":"first","13":"instock","14":"shipping-taxable","15":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product\/7704","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/comments?post=7704"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/media\/2163"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/media?parent=7704"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product_brand?post=7704"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product_cat?post=7704"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product_tag?post=7704"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}